🇺🇸 NVP in United States

24 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Neuropathy Peripheral — 4 reports (16.67%)
  2. Fanconi Syndrome Acquired — 3 reports (12.5%)
  3. Nephropathy Toxic — 3 reports (12.5%)
  4. Acute Kidney Injury — 2 reports (8.33%)
  5. Anaemia — 2 reports (8.33%)
  6. Confusional State — 2 reports (8.33%)
  7. Drug Ineffective — 2 reports (8.33%)
  8. Duodenitis — 2 reports (8.33%)
  9. Gastritis — 2 reports (8.33%)
  10. Proteinuria — 2 reports (8.33%)

Source database →

NVP in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease / Virology approved in United States

Frequently asked questions

Is NVP approved in United States?

NVP does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for NVP in United States?

Johns Hopkins Bloomberg School of Public Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.